Sign In
Last checked at 
28 Nov 2025 16:34
28 November 2025
CVS Group plc
("CVS" or the "Company")
Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing
CVS Group plc (the "Company") announces that as part of its 2025/2026 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:
Richard Fairman 507 SAYE scheme options
Robin Alfonso 538 SAYE scheme options
Paul Higgs 538 SAYE scheme options
Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,136 pence per share, representing a 10% discount to the average closing middle market price for the three dealing days prior to 1 November 2025, being the invitation date.
In response to accepted invitations, a total of 370,637 SAYE Scheme options over Ordinary Shares were granted on 26 November 2025, equating to 0.52% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2029.
The notification below, made in accordance with the requirements of UK MAR, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR) cvsg@camarco.co.uk
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Richard Fairman | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | CVS Group plc | ||||
b) | LEI | 213800J41XDQ2NX48O05 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
b) | Nature of the transaction | Grant of Options under the SAYE Scheme. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
- Aggregated volume
- Price | |||||
e) | Date of the transaction | 26 November 2025 | ||||
f) | Place of the transaction | Off market | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Robin Alfonso | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Financial Officer | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | CVS Group plc | ||||
b) | LEI | 213800J41XDQ2NX48O05 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
b) | Nature of the transaction | Grant of Options under the SAYE Scheme. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
- Aggregated volume
- Price | |||||
e) | Date of the transaction | 26 November 2025 | ||||
f) | Place of the transaction | Off market | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Paul Higgs | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Veterinary Officer & Director | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | CVS Group plc | ||||
b) | LEI | 213800J41XDQ2NX48O05 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Options over Ordinary shares of 0.2 pence each
GB00B2863827 | ||||
b) | Nature of the transaction | Grant of Options under the SAYE Scheme. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
- Aggregated volume
- Price | |||||
e) | Date of the transaction | 26 November 2025 | ||||
f) | Place of the transaction | Off market | ||||
Follow the stocks
